Page 10 - Serum Institute Of India

Covid-19 pandemic: Second Covishield dose before 84 days allowed for some

The Co-WIN system will soon provide the facility for the administration of the second dose in such exceptional cases, the ministry said

Covishield shows better antibody response than Covaxin, says study

The study was aimed at analysing the antibody response after two complete doses of Covishield and Covaxin in Indians

Do not politicise GST Council: Finance Minister Nirmala Sitharaman

The government is conscious of the intensity of the second wave of Covid-19 and is assessing its full impact before coming out with further packages and interventions, says FM Sitharaman

Serum Institute gets DCGI's nod to manufacture Covid jab Sputnik V in India

Russia's Sputnik V vaccine is currently being manufactured by Dr Reddy's Laboratories in India.

Covid-19 pandemic: Serum Institute seeks indemnity for jab again

In talks with RDIF to manufacture Sputnik V in India

After Pfizer, Serum Institute seeks indemnity over Covid vaccine: Report

Amid discussions over possible legal protection to foreign vaccine manufacturers Pfizer and Moderna over their COVID-19 jabs in India, SII has also sought protection against liabilities

Serum Institute applies to DCGI to manufacture Covid vaccine Sputnik V

The Serum Institute of India has applied to DCGI seeking permission to manufacture Covid-19 vaccine Sputnik V in the country

Decoded: Who can get antibody cocktail for Covid-19 and how it works

Used to treat only mild to moderate disease in high-risk Covid-19 patients, doctors feel the treatment can bolster the fight against severe disease

Bombay HC asks Maha govt to address security concerns raised by Serum CEO

The Bombay High Court said the Maharashtra government must assure SII CEO of requisite security in the wake of alleged threats to him over the supply of the Covishield vaccine

Serum Institute's Adar Poonawalla appointed chairman of Magma Fincorp

Vijay Deshwal, currently with ICICI Bank as its business head, will take charge as CEO of Magma Fincorp in July

Will be able to manufacture, supply 100 mn Covishield doses in June: SII

Serum Institute of India (SII) has informed the government that it will be able to manufacture and supply nine to 100 million doses of Covishield in June

Shortage of transparency

Govt, companies must end opacity on vaccine supplies

ICMR to examine effectiveness of SII's Covishield, Bharat Biotech's Covaxin

The Indian Council of Medical Research (ICMR) will conduct a survey from next week to examine the effectiveness of these vaccines in preventing progression of COVID into a severe form.

India a dysfunctional anarchy?

It is the people who lost as the government scored self-goals

At current rate, India will vaccinate 75% population only by mid-2024

Asking rate in coming months is thrice the current vaccination rate, a tall order unless vaccine procurement is ramped up on a war footing

Delhi yet to receive more Covid-19 vaccines for 18-44 group, says Atishi

Delhi is yet to receive more vaccines for the 18-44 age group and only private hospitals are giving jabs to beneficiaries in this category for now, Aam Aadmi Party MLA Atishi said on Tuesday

Serum Institute disassociates from executive's remarks on Covid vaccination

Serum Institute has disassociated itself from its executive director's statement that govt began the Covid vaccination of multiple age groups without taking into consideration the available stock

India is world's vaccine factory: What happens when it can't deliver

India stopped exporting Covid-19 vaccines in mid-April, leaving low-income and lower-middle-income countries in the lurch.

SBI report pegs total Covid vaccination cost in India at Rs 3.7 trillion

Poorer states with high population would not be able to vaccinate themselves quickly. Richer states may have to pay a much steeper price given the global oligopolistic market, the report said

India's largest vial maker expects sales to triple on vaccine ramp up

Schott Kaisha is also in talks with Indian manufacturers of Russia's Sputnik V vaccine to supply millions of vials, but is yet to receive bulk orders